The immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome

European Journal of Immunology

Volumn 43, Issue 8, 2013, Pages 1995-2002

  Lai, Rachel P J ^a   Nakiwala, Justine K ^b,c,d   Meintjes, Graeme ^b,e   Wilkinson, Robert J ^a,b,e  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d MRC UVRI Uganda HIV Research Unit on AIDS   (Uganda)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Drug therapy complications; HIV 1 infection; Immune reconstitution inflammatory syndrome; Tuberculosis

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; CYTOKINE RESPONSE; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MIXED INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE; TUBERCULOSIS;

DRUG THERAPY COMPLICATIONS; HIV-1 INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; TUBERCULOSIS;

ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COINFECTION; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; RISK FACTORS; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 84881538440     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343632     Document Type: Article

References (71)

1. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M. C., Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999. 282: 677-686.
2. Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C. and Dye, C., The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 2003. 163: 1009-1021.
3. WHO, World Health Organization: Tuberculosis - Global Facts 2011/2012. WHO Stop TB Dep, Geneva, 2012. http://www.who.int/tb/publications/global_report/gtbr12_main.pdf
4. Suthar, A. B., Lawn, S. D., del Amo, J., Getahun, H., Dye, C., Sculier, D., Sterling, T. R. et al., Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012. 9: e1001270.
5. Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C. et al., Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997. 277: 112-116.
6. French, M. A., Mallal, S. A. and Dawkins, R. L., Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992. 6: 1293-1297.
7. Lawn, S. D., Bekker, L. G. and Miller, R. F., Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect. Dis. 2005. 5: 361-373.
8. Jaffe, H. W., De Stavola, B. L., Carpenter, L. M., Porter, K., Cox, D. R. and Collaboration, C., Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS 2011. 25: 1395-1403.
9. Ramdial, P. K., Sing, Y., Subrayan, S. and Calonje, E., Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis. Am. J. Dermatopathol. 2010. 32: 780-786.
10. French, M. A., Price, P. and Stone, S. F., Immune restoration disease after antiretroviral therapy. AIDS 2004. 18: 1615-1627.
11. Muller, M., Wandel, S., Colebunders, R., Attia, S., Furrer, H., Egger, M., Ie, D. E. A. S. et al., Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect. Dis. 2010. 10: 251-261.
12. Davies, M. A. and Meintjes, G., Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin. Infect. Dis. 2009. 49: 973-975.
13. Lange, C. and Sester, M., TB or not TB: the role of immunodiagnosis. Eur. J. Immunol. 2012. 42: 2840-2843.
14. Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H. et al., Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect. Dis. 2008. 8: 516-523.
15. Lesho, E., Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome. Expert Rev. Anti. Infect. Ther. 2006. 4: 469-478.
16. Marais, S., Wilkinson, R. J., Pepper, D. J. and Meintjes, G., Management of patients with the immune reconstitution inflammatory syndrome. Curr. HIV/peR SDIA 2009. 6: 162-171.
17. Olalla, J., Pulido, F., Rubio, R., Costa, M. A., Monsalvo, R., Palenque, E., Costa, J. R. et al., Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease. Int. J. Tuberc. Lung Dis. 2002. 6: 71-75.
18. Ratnam, I., Chiu, C., Kandala, N. B. and Easterbrook, P. J., Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin. Infect. Dis. 2006. 42: 418-427.
19. Bourgarit, A., Carcelain, G., Martinez, V., Lascoux, C., Delcey, V., Gicquel, B., Vicaut, E. et al., Explosion of tuberculin-specific Th1 responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006. 20: F1-F7.
20. Navas, E., Martin-Davila, P., Moreno, L., Pintado, V., Casado, J. L., Fortun, J., Perez-Elias, M. J. et al., Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch. Intern. Med. 2002. 162: 97-99.
21. Tansuphasawadikul, S., Saito, W., Kim, J., Phonrat, B., Dhitavat, J., Chamnachanan, S. and Pitisuttithum, P., Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis. Southeast Asian J. Trop. Med. Public Health 2007. 38: 1053-1060.
22. Manosuthi, W., Kiertiburanakul, S., Phoorisri, T. and Sungkanuparph, S., Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J. Infect. 2006. 53: 357-363.
23. Burman, W., Weis, S., Vernon, A., Khan, A., Benator, D., Jones, B., Silva, C. et al., Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int. J. Tuberc. Lung Dis. 2007. 11: 1282-1289.
24. Asselman, V., Thienemann, F., Pepper, D. J., Boulle, A., Wilkinson, R. J., Meintjes, G. and Marais, S., Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS 2010. 24: 2871-2876.
25. Marais, S., Meintjes, G., Pepper, D. J., Dodd, L. E., Schutz, C., Ismail, Z., Wilkinson, K. A. et al., Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin. Infect. Dis. 2013. 56: 450-460.
26. Pepper, D. J., Marais, S., Maartens, G., Rebe, K., Morroni, C., Rangaka, M. X., Oni, T. et al., Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin. Infect. Dis. 2009. 48: e96-e107.
27. Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A. L., Gengiah, T. et al., Integration of antiretroviral therapy with tuberculosis treatment. N. Engl. J. Med. 2011. 365: 1492-1501.
28. Blanc, F. X., Sok, T., Laureillard, D., Borand, L., Rekacewicz, C., Nerrienet, E., Madec, Y. et al., Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N. Engl. J. Med. 2011. 365: 1471-1481.
29. Havlir, D. V., Kendall, M. A., Ive, P., Kumwenda, J., Swindells, S., Qasba, S. S., Luetkemeyer, A. F. et al., Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N. Engl. J. Med. 2011. 365: 1482-1491.
30. Meintjes, G., Wilkinson, K. A., Rangaka, M. X., Skolimowska, K., van Veen, K., Abrahams, M., Seldon, R. et al., Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med. 2008. 178: 1083-1089.
31. Tieu, H. V., Ananworanich, J., Avihingsanon, A., Apateerapong, W., Sirivichayakul, S., Siangphoe, U., Klongugkara, S. et al., Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand. AIDS Res. Hum. Retroviruses 2009. 25: 1083-1089.
32. Elliott, J. H., Vohith, K., Saramony, S., Savuth, C., Dara, C., Sarim, C., Huffam, S. et al., Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J. Infect. Dis. 2009. 200: 1736-1745.
33. Antonelli, L. R., Mahnke, Y., Hodge, J. N., Porter, B. O., Barber, D. L., DerSimonian, R., Greenwald, J. H. et al., Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 2010. 116: 3818-3827.
34. Mahnke, Y. D., Greenwald, J. H., DerSimonian, R., Roby, G., Antonelli, L. R., Sher, A., Roederer, M. et al., Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. Blood 2012. 119: 3105-3112.
35. Sakaguchi, S., Naturally arising Foxp3-expressing CD25+CD4 +regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005. 6: 345-352.
36. Guyot-Revol, V., Innes, J. A., Hackforth, S., Hinks, T. and Lalvani, A., Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 2006. 173: 803-810.
37. Scott-Browne, J. P., Shafiani, S., Tucker-Heard, G., Ishida-Tsubota, K., Fontenot, J. D., Rudensky, A. Y., Bevan, M. J. et al., Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 2007. 204: 2159-2169.
38. Seddiki, N., Sasson, S. C., Santner-Nanan, B., Munier, M., van Bockel, D., Ip, S., Marriott, D. et al., Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur. J. Immunol. 2009. 39: 391-403.
39. Tan, D. B., Yong, Y. K., Tan, H. Y., Kamarulzaman, A., Tan, L. H., Lim, A., James, I. et al., Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 2008. 9: 307-316.
40. Janis, E. M., Kaufmann, S. H., Schwartz, R. H. and Pardoll, D. M., Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science 1989. 244: 713-716.
41. Bourgarit, A., Carcelain, G., Samri, A., Parizot, C., Lafaurie, M., Abgrall, S., Delcey, V. et al., Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. J. Immunol. 2009. 183: 3915-3923.
42. Lim, A., D'Orsogna, L., Price, P. and French, M. A., Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease. AIDS Res. Ther. 2008. 5: 9.
43. Skolimowska, K. H., Rangaka, M. X., Meintjes, G., Pepper, D. J., Seldon, R., Matthews, K., Wilkinson, R. J. et al., Altered ratio of IFN-gamma/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV-tuberculosis immune reconstitution inflammatory syndrome. PLoS One 2012. 7: e46481.
44. Tadokera, R., Meintjes, G., Skolimowska, K. H., Wilkinson, K. A., Matthews, K., Seldon, R., Chegou, N. N. et al., Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur. Respir. J. 2011. 37: 1248-1259.
45. Grant, P. M., Komarow, L., Lederman, M. M., Pahwa, S., Zolopa, A. R., Andersen, J., Asmuth, D. M. et al., Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. J. Infect. Dis. 2012. 206: 1715-1723.
46. Morlese, J. F., Orkin, C. M., Abbas, R., Burton, C., Qazi, N. A., Nelson, M. R., Imami, N. et al., Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection. AIDS 2003. 17: 1411-1413.
47. Worsley, C. M., Suchard, M. S., Stevens, W. S., Van Rie, A. and Murdoch, D. M., Multi-analyte profiling of ten cytokines in South African HIV-infected patients with immune reconstitution inflammatory syndrome (IRIS). AIDS Res. Ther. 2010. 7: 36.
48. Tadokera, R., Wilkinson, K. A., Meintjes, G. A., Skolimowska, K. H., Matthews, K., Seldon, R., Rangaka, M. X. et al., Role of the interleukin 10 family of xytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis. J. Infect. Dis. 2013. 207: 1148-1156.
49. Oliver, B. G., Elliott, J. H., Price, P., Phillips, M., Saphonn, V., Vun, M. C., Kaldor, J. M. et al., Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J. Infect. Dis. 2010. 202: 1728-1737.
50. Rubino, S. J., Geddes, K. and Girardin, S. E., Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 2012. 33: 112-118.
51. Sutton, C. E., Mielke, L. A. and Mills, K. H., IL-17-producing gammadelta T cells and innate lymphoid cells. Eur. J. Immunol. 2012. 42: 2221-2231.
52. Arend, W. P., Palmer, G. and Gabay, C., IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008. 223: 20-38.
53. Martineau, A. R., Nhamoyebonde, S., Oni, T., Rangaka, M. X., Marais, S., Bangani, N., Tsekela, R. et al., Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc. Natl. Acad. Sci. USA 2011. 108: 19013-19017.
54. Coussens, A. K., Wilkinson, R. J., Hanifa, Y., Nikolayevskyy, V., Elkington, P. T., Islam, K., Timms, P. M. et al., Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc. Natl. Acad. Sci. USA 2012. 109: 15449-15454.
55. Conesa-Botella, A., Meintjes, G., Coussens, A. K., van der Plas, H., Goliath, R., Schutz, C., Moreno-Reyes, R. et al., Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin. Infect. Dis. 2012. 55: 1004-1011.
56. Price, P., Morahan, G., Huang, D., Stone, E., Cheong, K. Y., Castley, A., Rodgers, M. et al., Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002. 16: 2043-2047.
57. Affandi, J. S., Kumar, M., Agarwal, U., Singh, S. and Price, P., The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis. Dis. Markers 2013. 34: 445-449.
58. Van den Bergh, R., Vanham, G., Raes, G., De Baetselier, P. and Colebunders, R., Mycobacterium-associated immune reconstitution disease: macrophages running wild? Lancet Infect. Dis. 2006. 6: 2-3.
59. Lawn, S. D., Wainwright, H. and Orrell, C., Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 2009. 23: 143-145.
60. Tran, H. T., Van den Bergh, R., Loembe, M. M., Worodria, W., Mayanja-Kizza, H., Colebunders, R., Mascart, F. et al., Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2013. 27: 1725-1734.
61. Janeway, C. A., Jr. and Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 2002. 20: 197-216.
62. Conradie, F., Foulkes, A. S., Ive, P., Yin, X., Roussos, K., Glencross, D. K., Lawrie, D. et al., Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection. J. Acquir. Immune Defic. Syndr. 2011. 58: 309-318.
63. Haddow, L. J., Dibben, O., Moosa, M. Y., Borrow, P. and Easterbrook, P. J., Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2011. 25: 1163-1174.
64. Porter, B. O., Ouedraogo, G. L., Hodge, J. N., Smith, M. A., Pau, A., Roby, G., Kwan, R. et al., d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clin. Immunol. 2010. 136: 42-50.
65. McGrath, F. D., Brouwer, M. C., Arlaud, G. J., Daha, M. R., Hack, C. E. and Roos, A., Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 2006. 176: 2950-2957.
66. Reiling, N., Holscher, C., Fehrenbach, A., Kroger, S., Kirschning, C. J., Goyert, S. and Ehlers, S., Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 2002. 169: 3480-3484.
67. Tan, D. B., Lim, A., Yong, Y. K., Ponnampalavanar, S., Omar, S., Kamarulzaman, A., French, M. A. et al., TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 2011. 25: 1455-1460.
68. Pean, P., Nerrienet, E., Madec, Y., Borand, L., Laureillard, D., Fernandez, M., Marcy, O. et al., Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood 2012. 119: 3315-3320.
69. Berry, M. P., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A., Oni, T., Wilkinson, K. A. et al., An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010. 466: 973-977.
70. Simonney, N., Dewulf, G., Herrmann, J. L., Gutierrez, M. C., Vicaut, E., Boutron, C., Leportier, M. et al., Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients. Tuberculosis (Edinb) 2008. 88: 453-461.
71. Barber, D. L., Mayer-Barber, K. D., Antonelli, L. R., Wilson, M. S., White, S., Caspar, P., Hieny, S. et al., Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 2010. 116: 3485-3493.